Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Akt1 S2152-p
CAMK2A S2523-p
CDK4 S1459-p , S2152-p
CDK6 S1459-p , S2152-p
p90RSK S2152-p
PAK1 S2152-p
PKACA S2152-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

CDK1 S1084-p , S1436-p , S1459-p , S1533-p , S1630-p
p90RSK S2152-p
PAK1 S2152-p , S2292-p , S2370-p
PKACA S2152-p
PKACA S2152-p
PKACA S2152-p
TAK1 T1286-p
Putative upstream phosphatases:
PPP3CA S2152-p
Regulatory protein:
IL24 S2152-p
JAK2 S2152-p
LPAR1 S2152-p
A23187 S2152-p
angiotensin-(1-7) S1459-p
angiotensin_2 S2152-p , S2158-p
antibody S394-p , S1084-p , S1459-p , S2152-p , S2158-p , S2180-p , T2209-p , T2336-p
As3+ S2152-p
Ca(2+) S2152-p
ciclosporin S2152-p
colforsin S2152-p
crizotinib S2152-p
EGF S1084-p , S2053-p , S2152-p
fluorouracil S2152-p
HA-1004 S2152-p
heregulin S2152-p
HGF S2152-p
IBMX S2152-p
insulin S2152-p
ischemia S2327-p
Ki16425 S2152-p
KN-93 S2523-p
LPA S2152-p
LY294002 S2152-p
MLN8054 T2062-p
nocodazole S1081-p , S1084-p , S1459-p , S1533-p , S1946-p , S2053-p , S2128-p , S2284-p , S2327-p , T2336-p , S2414-p , S2510-p
peptide inhibitor S2152-p
PGE2 S2152-p , T2336-p
selumetinib S1084-p , S2319-p
serum S2152-p
thrombin S2523-p
U0126 S1533-p , S2152-p
vemurafenib S1084-p , S2319-p
wortmannin S2152-p